Gastrointestinal
News on in vitro diagnostics for gastrointestinal disease.
Lucid Diagnostics Obtains CE Mark for Esophageal Cancer Molecular Test
Lucid said that key opinion leaders for esophageal disease in Europe are participating in pivotal clinical trials for the test and its collection device.
The firm is expanding its plans from a Crohn's disease test to a broader GI differential diagnostic and continues to expect to launch its Lyme disease assay by year-end.
Prometheus Biosciences Prices Upsized $190M IPO
The company is focused on developing and commercializing therapeutic and companion diagnostic products to treat inflammatory bowel disease.
ABO Histo-Blood Groups Influence Makeup of Gut Microbiome, New Study Finds
The findings further suggested the gut microbiome could influence conditions like inflammatory bowel disease and serve as therapeutic targets.
Single-Cell Transcriptome Study Links Gut Development, Pediatric Crohn's Disease
Researchers saw transcription factor similarities between developing human intestinal cells and cells from pediatric Crohn's disease cases.